marijuana stocks news

American Cannabis Company, Inc. (AMMJ)

 

Income Statement Get Income Statement for:
View: Annual Data | Quarterly Data All numbers in thousands
Period Ending Dec 31, 2014 Sep 30, 2014 Jun 30, 2014 Mar 31, 2014
Total Revenue 640   (3,848) 2,585   1,881  
Cost of Revenue 416 (3,683) 2,180 1,859
Gross Profit 224   (164) 406   22  
Operating Expenses
Research Development 13
Selling General and Administrative 3,588 (1,758) 1,752 283
Non Recurring
Others
Total Operating Expenses
Operating Income or Loss (3,377) 1,594   (1,346) (262)
Income from Continuing Operations
Total Other Income/Expenses Net 96
Earnings Before Interest And Taxes (3,605) 1,497 (1,250) (262)
Interest Expense (1) (82) 49 34
Income Before Tax (3,604) 1,579 (1,299) (296)
Income Tax Expense 12 (65)
Minority Interest
Net Income From Continuing Ops (3,569) 1,526 (1,311) (231)
Non-recurring Events
Discontinued Operations
Extraordinary Items
Effect Of Accounting Changes
Other Items
Net Income (3,604) 1,526   (1,311) (231)
Preferred Stock And Other Adjustments
Net Income Applicable To Common Shares (3,604) 1,526   (1,311) (231)

MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

$VNNYF Develops a Disruptive Solvent Based Extraction System

Vinergy Resources/MJ BioPharma Develops a Disruptive Solvent Based Extraction System  Vinergy Resources…

$MYEC Launches “e” Mobile Commerce

MyECheck Launches “e” Mobile Commerce Revolutionary Billing and Payment Apps Uploaded to…

ParcelPal Technology Inc. (PTNYF) (PKG.CN) Announces Call-in Details for Quarterly Reporting Call to Take Place on May 17, 2019

ParcelPal Announces Call-in Details for Quarterly Reporting Call to Take Place on…

$OXIS Begins Enrolling and Treating Patients in FDA Phase 1/Phase 2 Clinical Trial

Oxis Begins Enrolling and Treating Patients in FDA Phase 1/Phase 2 Clinical…